Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL

Magalhães Rego, Eduardo; T. Kim, Haesook; J. Ruíz‐Argüelles, Guillermo; Soledad Undurraga, María; del Rosario Uriarte, Marı́a; Henriques Jácomo, Rafael; Homero Gutiérrez‐Aguirre, Cesar; Antônio Morais Melo, Raul; Bittencourt, Rosane; Pasqüini, Ricardo; Bórgia Barbosa Pagnano, Kátia; M. Fagundes, Evandro; de Lourdes Chauffaille, Maria; Chiattone, Carlos; Martínez, Lem; Meillón, Luis; Gómez‐Almaguer, David; C. Kwaan, Hau; Garcés‐Eisele, Javier; E. Gallagher, Robert; M. Niemeyer, Charlotte; L. Schrier, Stanley; S. Tallman, Martin; Grimwade, David; Ganser, Arnold; Berliner, Nancy; C. Ribeiro, Raul; Lo‐Coco, Francesco; Löwenberg, Bob; Á. Sanz, Miguel

doi:10.1182/blood-2012-08-449918

Public

Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL

Published in Blood • Jan 14, 2013

Authors:

Eduardo Magalhães Rego

Haesook T. Kim

Guillermo J. Ruíz‐Argüelles

Abstract

Thanks to modern treatment with all-trans retinoic acid and chemotherapy, acute promyelocytic leukemia (APL) is now the most curable type of leukemia. However, this progress has not yielded equivalent benefit in developing countries. The International Consortium on Acute Promyelocytic Leukemia (IC-A...

Subject

Acute promyelocytic leukemia

Developing country

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!